A complete application in a minute
Tailored resume and cover letter, ready to send.
CNRS Lyon Cancer Research Center (CRCL) invites applications for a First Stage Researcher (R1) to join the Apoptosis, Cancer, and Development team led by Patrick MEHLEN, studying UNC5B-induced cell death. The position is based in Lyon, France, under a temporary contract with 35 hours per week.
Responsibilities include conducting cellular biology experiments, validating protein targets from interaction screening and MS screening, and performing cell death assays in the presence or absence of the
Organisation/Company CNRS Department Centre de recherche en canc�rologie de Lyon Research Field Biological sciences Biological sciences Biology Researcher Profile First Stage Researcher (R1) Application Deadline 19 Nov 2026 - 23:59 (UTC) Country France Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 1 Dec 2026 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
The Lyon Cancer Research Center (CRCL) is a center of excellence dedicated to cancer research.
The CRCL is a collaborative effort involving several major French institutions that brings together researchers, physicians, engineers, technicians, and biologists:
The employee will join our academic laboratory specializing in oncology, within the "Apoptosis, Cancer, and Development" team led by Patrick MEHLEN, to study how the UNC5B receptor induces cell death.
As a CNRS employee, you will have access to a staff cafeteria offering lunch at an affordable price, partial reimbursement of transit fares (75%) plus a sustainable mobility allowance of up to €300 per year, and a staff welfare and mutual aid committee.
The candidate will primarily conduct cellular biology experiments to characterize the mechanisms of cell death induction.
The candidate will be expected to: